The Munich vulnerability study on affective disorders: microstructure of sleep in high-risk subjects.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 2755744)

Published in Eur Arch Psychiatry Clin Neurosci on May 26, 2008

Authors

Elisabeth Friess1, Sieglinde Modell, Hans Brunner, Hirokuni Tagaya, Christoph J Lauer, Florian Holsboer, Marcus Ising

Author Affiliations

1: Max Planck Institute of Psychiatry, 80804, Munich, Germany. friess@mpipsykl.mpg.de

Articles cited by this

Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard. Psychiatry Clin Neurosci (2001) 36.50

Thalamocortical oscillations in the sleeping and aroused brain. Science (1993) 10.02

Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci (1995) 4.02

The effects of age and gender on sleep EEG power spectral density in the middle years of life (ages 20-60 years old). Psychophysiology (2001) 3.15

Learning-dependent increases in sleep spindle density. J Neurosci (2002) 2.98

Reduced sleep spindle activity in schizophrenia patients. Am J Psychiatry (2007) 2.26

Trait interindividual differences in the sleep physiology of healthy young adults. J Sleep Res (2007) 1.84

Dynamics of electroencephalographic sleep spindles and slow wave activity in men: effect of sleep deprivation. Brain Res (1993) 1.64

The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol Psychiatry (2005) 1.57

Prediction of general mental ability based on neural oscillation measures of sleep. J Sleep Res (2005) 1.51

An electroencephalographic fingerprint of human sleep. Neuroimage (2005) 1.46

Spindle frequency activity in the sleep EEG: individual differences and topographic distribution. Electroencephalogr Clin Neurophysiol (1997) 1.45

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology (1995) 1.38

High resolution study of sleep spindles. Clin Neurophysiol (1999) 1.37

Sleep and the sleep electroencephalogram across the menstrual cycle in young healthy women. J Clin Endocrinol Metab (1996) 1.32

Trait-like individual differences in the human sleep electroencephalogram. Neuroscience (2006) 1.23

Twenty-four hours retention of visuospatial memory correlates with the number of parietal sleep spindles. Neurosci Lett (2006) 1.21

Electroencephalographic sleep correlates of episode and vulnerability to recurrence in depression. Biol Psychiatry (1997) 1.17

Sleep spindles. J Clin Neurophysiol (1985) 1.12

Sleep research in affective illness: state of the art circa 1987. Sleep (1987) 1.11

Topographical analysis of sleep spindle activity. Neuropsychobiology (1992) 1.11

Sleep and treatment response in depression: new findings using power spectral analysis. Psychiatry Res (2001) 1.08

Electroencephalographic sleep profiles before and after cognitive behavior therapy of depression. Arch Gen Psychiatry (1998) 1.03

Progesterone-induced changes in sleep in male subjects. Am J Physiol (1997) 1.00

Dynamics of EEG spindle frequency activity during extended sleep in humans: relationship to slow-wave activity and time of day. Brain Res (1997) 0.99

A study on gender and age differences in sleep spindles. Neuropsychobiology (2002) 0.99

Controlled comparison of electrophysiological sleep in families of probands with unipolar depression. Am J Psychiatry (1998) 0.97

Development of sleep spindles in young children and adolescents. Clin Electroencephalogr (1999) 0.96

Sleep spindle activity changes in patients with affective disorders. Sleep (1987) 0.94

Reduced rapid eye movement latency. A predictor of recurrence in depression. Neuropsychopharmacology (1987) 0.92

EEG slow waves and sleep spindles: windows on the sleeping brain. Behav Brain Res (1995) 0.92

In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry (1995) 0.88

Delta sleep ratio as a predictor of sleep deprivation response in major depression. J Psychiatr Res (2001) 0.86

Ontogenesis of nocturnal organization of sleep spindles: a longitudinal study during the first 6 months of life. Electroencephalogr Clin Neurophysiol (1992) 0.85

Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord (1989) 0.85

Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response. J Psychiatr Res (2004) 0.85

Sleep electroencephalographic coherence abnormalities in individuals at high risk for depression: a pilot study. Biol Psychiatry (2000) 0.84

Acute cortisol administration promotes sleep intensity in man. Neuropsychopharmacology (2004) 0.81

Biological rhythm disturbance in depression: temporal coherence of ultradian sleep EEG rhythms. Psychol Med (1999) 0.81

The Munich Vulnerability Study on Affective Disorders: stability of polysomnographic findings over time. Biol Psychiatry (2002) 0.81

Electroencephalographic sleep studies in depressed patients during long-term recovery. Psychiatry Res (1993) 0.79

Temporal EEG dynamics of non-REM sleep episodes in humans. Brain Res (2000) 0.79

Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86. J Clin Psychopharmacol (2004) 0.78

Concurrent occurrence of rapid eye movement with spindle burst during nocturnal sleep in mentally retarded children. Electroencephalogr Clin Neurophysiol (1982) 0.78

Preliminary evidence of an association between increased REM density and poor antidepressant response to partial sleep deprivation. J Affect Disord (2000) 0.78

Comparison between eye movement latency and REM sleep parameters in major depression. Eur Arch Psychiatry Clin Neurosci (2000) 0.77

Articles by these authors

Stress and the brain: from adaptation to disease. Nat Rev Neurosci (2005) 9.48

Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34

Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71

Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet (2007) 4.54

Dynamic DNA methylation programs persistent adverse effects of early-life stress. Nat Neurosci (2009) 4.53

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet (2004) 3.91

Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73

FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem (2004) 2.91

Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat Neurosci (2003) 2.79

Meta-analysis of genome-wide association data identifies a risk locus for major mood disorders on 3p21.1. Nat Genet (2010) 2.46

RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell (2007) 2.34

Genome-wide association study of major recurrent depression in the U.K. population. Am J Psychiatry (2010) 2.17

Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry (2011) 2.09

The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron (2011) 2.02

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol (2002) 1.97

Enhanced and delayed stress-induced alcohol drinking in mice lacking functional CRH1 receptors. Science (2002) 1.93

Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry (2009) 1.88

Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci (2008) 1.88

Gene expression patterns associated with posttraumatic stress disorder following exposure to the World Trade Center attacks. Biol Psychiatry (2009) 1.85

Development of the brain's default mode network from wakefulness to slow wave sleep. Cereb Cortex (2011) 1.79

PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet (2008) 1.78

Central CRH system in depression and anxiety--evidence from clinical studies with CRH1 receptor antagonists. Eur J Pharmacol (2008) 1.76

Reduced anxiety, conditioned fear, and hippocampal long-term potentiation in transient receptor potential vanilloid type 1 receptor-deficient mice. J Neurosci (2007) 1.70

Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1. Science (2011) 1.64

Stress hormone regulation: biological role and translation into therapy. Annu Rev Psychol (2010) 1.64

Polymorphisms of the glucocorticoid receptor gene and major depression. Biol Psychiatry (2006) 1.62

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One (2010) 1.62

EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units. Eur J Hum Genet (2010) 1.62

Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects. Science (2009) 1.61

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry (2005) 1.61

The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol Psychiatry (2005) 1.57

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression. Neuron (2008) 1.57

GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. Am J Psychiatry (2002) 1.56

Increased stress reactivity is associated with reduced hippocampal activity and neuronal integrity along with changes in energy metabolism. Eur J Neurosci (2012) 1.54

The combined dexamethasone/CRH test as a potential surrogate marker in depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 1.52

Putative biological mechanisms for the association between early life adversity and the subsequent development of PTSD. Psychopharmacology (Berl) (2010) 1.49

Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways. Mol Endocrinol (2002) 1.47

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res (2008) 1.45

Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker? Biol Psychiatry (2006) 1.44

P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet (2006) 1.42

Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci (2005) 1.40

Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. J Clin Psychiatry (2015) 1.39

Genome-wide significant association between alcohol dependence and a variant in the ADH gene cluster. Addict Biol (2011) 1.37

FK506 binding protein 5 shapes stress responsiveness: modulation of neuroendocrine reactivity and coping behavior. Biol Psychiatry (2011) 1.37

Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry (2011) 1.33

Dreamed movement elicits activation in the sensorimotor cortex. Curr Biol (2011) 1.27

Altered processing of acoustic stimuli during sleep: reduced auditory activation and visual deactivation detected by a combined fMRI/EEG study. Neuroimage (2002) 1.26

Neuroendocrine, cognitive and structural imaging characteristics of women on longterm sickleave with job stress-induced depression. Biol Psychiatry (2006) 1.23

Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? Nat Rev Drug Discov (2012) 1.22

Increased sleep pressure reduces resting state functional connectivity. MAGMA (2010) 1.21

Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet (2006) 1.20

Long-term behavioral and neuroendocrine alterations following chronic social stress in mice: implications for stress-related disorders. Horm Behav (2007) 1.20

Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci U S A (2003) 1.20

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol Psychiatry (2003) 1.19

Heritability of sleep electroencephalogram. Biol Psychiatry (2008) 1.19

Essential role of the unusual DNA-binding motif of BAG-1 for inhibition of the glucocorticoid receptor. J Biol Chem (2002) 1.19

Neural correlates of dream lucidity obtained from contrasting lucid versus non-lucid REM sleep: a combined EEG/fMRI case study. Sleep (2012) 1.19

Overweight and obesity affect treatment response in major depression. Biol Psychiatry (2007) 1.18

Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology (2004) 1.17

Depletion of the neural precursor cell pool by glucocorticoids. Ann Neurol (2010) 1.17

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurol (2006) 1.17

Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology (2012) 1.16

Effects of transgenic overproduction of CRH on anxiety-like behaviour. Eur J Neurosci (2002) 1.15

The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stress. Neuropharmacology (2011) 1.15

Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol Psychiatry (2011) 1.14

Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry. Electrophoresis (2004) 1.13

Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. Neuropsychopharmacology (2009) 1.12

Functional MRI during sleep: BOLD signal decreases and their electrophysiological correlates. Eur J Neurosci (2004) 1.12

Effects of rapid eye movement sleep deprivation on fear extinction recall and prediction error signaling. Hum Brain Mapp (2011) 1.12

Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. J Neuroimmunol (2010) 1.12

Impaired repression at a vasopressin promoter polymorphism underlies overexpression of vasopressin in a rat model of trait anxiety. J Neurosci (2004) 1.11

Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Dis Markers (2011) 1.11

Clinical analyses of sighted patients with non-24-hour sleep-wake syndrome: a study of 57 consecutively diagnosed cases. Sleep (2005) 1.11

Transcriptional activities of the zinc finger protein Zac are differentially controlled by DNA binding. Mol Cell Biol (2003) 1.10

Sleep spindles and hippocampal functional connectivity in human NREM sleep. J Neurosci (2011) 1.10

Functional microstates within human REM sleep: first evidence from fMRI of a thalamocortical network specific for phasic REM periods. Eur J Neurosci (2007) 1.10

Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease. Neurosci Lett (2005) 1.09

The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction. FASEB J (2007) 1.09